Recombinant Mycobacterium Tuberculosis Fusion Protein(EC)
重组结核杆菌融合蛋白(EC)
Report date: 2022/04/21 09:27:16
Base Information
Drug NameRecombinant Mycobacterium Tuberculosis Fusion Protein(EC)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2020/04/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC Code
Related LinksN/A